The parametric response map is an imaging biomarker for early cancer treatment outcome

被引:167
作者
Galban, Craig J. [1 ]
Chenevert, Thomas L. [1 ]
Meyer, Charles R. [1 ]
Tsien, Christina [2 ]
Lawrence, Theodore S. [2 ]
Hamstra, Daniel A. [2 ]
Junck, Larry [3 ]
Sundgren, Pia C. [1 ]
Johnson, Timothy D. [4 ]
Ross, David J. [2 ]
Rehemtulla, Alnawaz [1 ,2 ]
Ross, Brian D. [1 ]
机构
[1] Univ Michigan, Ctr Mol Imaging, Dept Radiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Mol Imaging, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Ctr Mol Imaging, Dept Neurol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Ctr Mol Imaging, Dept Biostat, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
FUNCTIONAL DIFFUSION MAP; CONTRAST-ENHANCED MRI; ADVANCED SOLID TUMORS; HIGH-GRADE GLIOMAS; PHASE-I; ANGIOGENESIS INHIBITOR; HISTOGRAM ANALYSIS; LIVER METASTASES; PROSTATE-CANCER; BREAST-TUMORS;
D O I
10.1038/nm.1919
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Here we describe the parametric response map (PRM), a voxel-wise approach for image analysis and quantification of hemodynamic alterations during treatment for 44 patients with high-grade glioma. Relative cerebral blood volume (rCBV) and flow (rCBF) maps were acquired before treatment and after 1 and 3 weeks of therapy. We compared the standard approach using region-of-interest analysis for change in rCBV or rCBF to the change in perfusion parameters on the basis of PRM (PRMrCBV and PRMrCBF) for their accuracy in predicting overall survival. Neither the percentage change of rCBV or rCBF predicted survival, whereas the regional response evaluations made on the basis of PRM were highly predictive of survival. Even when accounting for baseline rCBV, which is prognostic, PRMrCBV proved more predictive of overall survival.
引用
收藏
页码:572 / 576
页数:5
相关论文
共 33 条
[1]   Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series [J].
Brix, G ;
Kiessling, F ;
Lucht, R ;
Darai, S ;
Wasser, K ;
Delorme, S ;
Griebel, J .
MAGNETIC RESONANCE IN MEDICINE, 2004, 52 (02) :420-429
[2]   Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT. (vol 64, pg 876, 2006) [J].
Cao, Y ;
Tsien, CI ;
Nagesh, V ;
Junck, L ;
Ten Haken, R ;
Ross, BD ;
Chenevert, TL ;
Lawrence, TS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03) :960-960
[3]   Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy [J].
Chan, JL ;
Lee, SW ;
Fraass, BA ;
Normolle, DP ;
Greenberg, HS ;
Junck, LR ;
Gebarski, SS ;
Sandler, HM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1635-1642
[4]   Mapping pathophysiological features of breast tumors by MRI at high spatial resolution [J].
Degani, H ;
Gusis, V ;
Weinstein, D ;
Fields, S ;
Strano, S .
NATURE MEDICINE, 1997, 3 (07) :780-782
[5]   Model-based and model-free parametric analysis of breast dynamic-contrast-enhanced MRI [J].
Eyal, Evez ;
Degani, Hadassa .
NMR IN BIOMEDICINE, 2009, 22 (01) :40-53
[6]   Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis [J].
Galbraith, SM ;
Lodge, MA ;
Taylor, NJ ;
Rustin, GJS ;
Bentzen, S ;
Stirling, JJ ;
Padhani, AR .
NMR IN BIOMEDICINE, 2002, 15 (02) :132-142
[7]   Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma [J].
Hamstra, DA ;
Chenevert, TL ;
Moffat, BA ;
Johnson, TD ;
Meyer, CR ;
Mukherji, SK ;
Quint, DJ ;
Gebarski, SS ;
Fan, XY ;
Tsien, CI ;
Lawrence, TS ;
Junck, L ;
Rehemtulla, A ;
Ross, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (46) :16759-16764
[8]   PHARMACOKINETIC MAPPING OF THE BREAST - A NEW METHOD FOR DYNAMIC MR MAMMOGRAPHY [J].
HOFFMANN, U ;
BRIX, G ;
KNOPP, MV ;
HESS, T ;
LORENZ, WJ .
MAGNETIC RESONANCE IN MEDICINE, 1995, 33 (04) :506-514
[9]   Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker [J].
Hylton, Nola .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) :3293-3298
[10]   Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging [J].
Kiessling, F. ;
Morgenstern, B. ;
Zhang, C. .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (01) :77-91